Medicare official admits: there are no firm rules
This article was originally published in Clinica
The US agency responsible for overseeing the financing of healthcare for the elderly admits it has no hard and fast rules on what medical products and technology are covered.
You may also be interested in...
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.